IP Verse

Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias

Patent No. EP2988750 (titled "Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias") was filed by AOP Orphan Pharmaceuticals on Apr 25, 2014. The application was issued on Sep 17, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BECKEROct 18, 2022BECKER KURIG & PARTNER PATENTANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2988750

AOP ORPHAN PHARMACEUTICALS
Application Number
EP14720107A
Filing Date
Apr 25, 2014
Status
Patent Maintained As Amended
Apr 25, 2025
Publication Date
Sep 17, 2025
External Links
Slate, Register , Google Patents